LADENBURG THALMANN FINANCIAL SERVICES INC. - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 74 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q1 2016. The put-call ratio across all filers is 0.28 and the average weighting 1.2%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q1 2019$01250.0%0.00%
Q4 2018$0
-100.0%
125
-99.0%
0.00%
Q1 2016$12,000
-29.4%
12,933
-0.5%
0.00%
Q4 2015$17,000
-41.4%
12,993
+0.5%
0.00%
-100.0%
Q3 2015$29,000
+38.1%
12,9330.0%0.00%
Q2 2015$21,0000.0%12,9330.0%0.00%
Q1 2015$21,000
-12.5%
12,9330.0%0.00%
-100.0%
Q4 2014$24,000
+41.2%
12,9330.0%0.00%
Q3 2014$17,00012,9330.00%
Other shareholders

There were no reported owners of NAVIDEA BIOPHARMACEUTICALS I in Q1 2016.

NameSharesValueWeighting ↓
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders